Authors:
RUDD JA
CHAN SW
NGAN MP
SCHIRNER M
TURSKI L
WAI MK
Citation: Ja. Rudd et al., THE ANTIEMETIC POTENTIAL OF ZK-200.775 IN THE FERRET AND SUNCUS-MURINUS - ROLE OF THE AMPA RECEPTOR, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4040-4040
Authors:
TURSKI L
HUTH A
SHEARDOWN M
MCDONALD F
NEUHAUS R
SCHNEIDER HH
DIRNAGL U
WIEGAND F
JACOBSEN P
OTTOW E
Citation: L. Turski et al., ZK200775 - A PHOSPHONATE QUINOXALINEDIONE AMPA ANTAGONIST FOR NEUROPROTECTION IN STROKE AND TRAUMA, Proceedings of the National Academy of Sciences of the United Statesof America, 95(18), 1998, pp. 10960-10965
Citation: L. Turski et al., GLUTAMATE IN NEURODEGENERATIVE DISORDERS - HYPOTHESES ON PATHOGENESISAND THERAPEUTIC STRATEGIES, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 12-12
Authors:
PINNA G
GALICI R
SCHNEIDER HH
STEPHENS DN
TURSKI L
Citation: G. Pinna et al., ALPRAZOLAM DEPENDENCE PREVENTED BY SUBSTITUTING WITH THE BETA-CARBOLINE ABECARNIL, Proceedings of the National Academy of Sciences of the United Statesof America, 94(6), 1997, pp. 2719-2723
Authors:
WULLNER U
LOSCHMANN PA
SCHULZ JB
SCHMID A
DRINGEN R
EBLEN F
TURSKI L
KLOCKGETHER T
Citation: U. Wullner et al., GLUTATHIONE DEPLETION POTENTIATES MPTP AND MPP(+) TOXICITY IN NIGRAL DOPAMINERGIC NEURONES, NeuroReport, 7(4), 1996, pp. 921-923
Citation: H. Bernert et L. Turski, TRAUMATIC BRAIN-DAMAGE PREVENTED BY THE NON-N-METHYL-D-ASPARTATE ANTAGONIST 3-DIHYDROXY-6-NITRO-7-SULFAMOYLBENZO[F]QUINOXALINE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(11), 1996, pp. 5235-5240
Authors:
KLOCKGETHER T
WULLNER U
STEINBACH JP
PETERSEN V
TURSKI L
LOSCHMANN PA
Citation: T. Klockgether et al., EFFECTS OF THE ANTIPARKINSONIAN DRUG BUDIPINE ON CENTRAL NEUROTRANSMITTER SYSTEMS, European journal of pharmacology, 301(1-3), 1996, pp. 67-73
Authors:
EBLEN F
LOSCHMANN PA
WULLNER U
TURSKI L
KLOCKGETHER T
Citation: F. Eblen et al., EFFECTS OF 7-NITROINDAZOLE, N-G-NITRO-L-ARGININE, AND D-CPPENE ON HARMALINE-INDUCED POSTURAL TREMOR, N-METHYL-D-ASPARTATE-INDUCED SEIZURES,AND LISURIDE-INDUCED ROTATIONS IN RATS WITH NIGRAL 6-HYDROXYDOPAMINE LESIONS, European journal of pharmacology, 299(1-3), 1996, pp. 9-16
Citation: Pa. Loschmann et al., MPTP-INDUCED DEGENERATION - INTERFERENCE WITH GLUTAMATERGIC TOXICITY, Journal of neural transmission. Supplementum, 1994, pp. 133-143
Authors:
CAVALHEIRO EA
FERNANDES MJ
TURSKI L
NAFFAHMAZZACORATTI MG
Citation: Ea. Cavalheiro et al., SPONTANEOUS RECURRENT SEIZURES IN RATS - AMINO-ACID AND MONOAMINE DETERMINATION IN THE HIPPOCAMPUS, Epilepsia, 35(1), 1994, pp. 1-11
Authors:
KLOCKGETHER T
JACOBSEN P
LOSCHMANN PA
TURSKI L
Citation: T. Klockgether et al., THE ANTIPARKINSONIAN AGENT BUDIPINE IS AN N-METHYL-D-ASPARTATE ANTAGONIST, Journal of neural transmission. Parkinson's disease and dementia section, 5(2), 1993, pp. 101-106
Citation: T. Klockgether et L. Turski, TOWARD AN UNDERSTANDING OF THE ROLE OF GLUTAMATE IN EXPERIMENTAL PARKINSONISM - AGONIST-SENSITIVE SITES IN THE BASAL GANGLIA, Annals of neurology, 34(4), 1993, pp. 585-593
Citation: Dn. Stephens et L. Turski, KINDLING TO THE BENZODIAZEPINE RECEPTOR INVERSE AGONIST, FG 7142 - EVIDENCE FOR INVOLVEMENT OF NMDA, BUT NOT NON-NMDA, GLUTAMATERGIC RECEPTORS, Neuropharmacology, 32(10), 1993, pp. 1011-1017
Citation: Kg. Steppuhn et L. Turski, DIAZEPAM DEPENDENCE PREVENTED BY GLUTAMATE ANTAGONISTS, Proceedings of the National Academy of Sciences of the United Statesof America, 90(14), 1993, pp. 6889-6893
Citation: L. Turski et Dn. Stephens, EFFECT OF THE BETA-CARBOLINE ABECARNIL ON SPINAL REFLEXES IN MICE ANDON MUSCLE TONE IN GENETICALLY SPASTIC RATS - A COMPARISON WITH DIAZEPAM, The Journal of pharmacology and experimental therapeutics, 267(3), 1993, pp. 1215-1220
Citation: Kg. Steppuhn et L. Turski, MODULATION OF THE SEIZURE THRESHOLD FOR EXCITATORY AMINO-ACIDS IN MICE BY ANTIEPILEPTIC DRUGS AND CHEMOCONVULSANTS, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1063-1070
Citation: L. Turski et Wa. Turski, TOWARDS AN UNDERSTANDING OF THE ROLE OF GLUTAMATE IN NEURODEGENERATIVE DISORDERS - ENERGY-METABOLISM AND NEUROPATHOLOGY, Experientia, 49(12), 1993, pp. 1064-1072